Oral drugs against COVID-19
Author(s) -
Gerd Mikus,
Kathrin I. Foerster,
Theresa Terstegen,
Cathrin J. Vogt,
André Said,
Martin Schulz,
Walter E. Haefeli
Publication year - 2022
Publication title -
deutsches ärzteblatt international
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.m2022.0152
Subject(s) - ritonavir , medicine , drug , drug interaction , pharmacology , covid-19 , medline , approved drug , cyp3a , intensive care medicine , cytochrome p450 , viral load , virology , virus , disease , metabolism , antiretroviral therapy , infectious disease (medical specialty) , law , political science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom